Institutional investors hold a majority ownership of ABT through the 74.18% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Medical Specialties industry. Last, during the quarter ended September 2017, these large investors purchased a net $4.2 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAPITAL RESEARCH & MANAGEMENT CO... Bought 20.3 Million shares of Abbott Laboratories
CITADEL ADVISORS LLC Bought 4.0 Million shares of Abbott Laboratories
MANAGED ACCOUNT ADVISORS LLC Bought 3.0 Million shares of Abbott Laboratories